Kidney Cancer Scotland
Create covid-free hubs for cancer patients, Trusts told
Trusts have been told to urgently reconfigure surgical cancer services into covid-free hubs to minimise the number of procedures being postponed. In... Read More
BBC’s George Alagiah on living with coronavirus and cancer
In these worrying times we live in, this is a positive story for all cancer patients. BBC newsreader George Alagiah, who is... Read More
Weak kidney cancer cells could serve as therapeutic target
Researchers at the University of Texas MD Anderson Cancer Center have made an important discovery about how some cancers rely on glucose... Read More
RAMPART UPDATE: Covid-19 Participant Information
The team of doctors and researchers responsible for the RAMPART study are reviewing the potential risks and benefit of the research on... Read More
Nivolumab+Sitravatinib Combo Impresses in RCC
Combining a broad-spectrum tyrosine kinase inhibitor (TKI) with an immune checkpoint inhibitor resulted in a high disease control rate in a preliminary... Read More
Grant Stewart New Chair of Surgical Oncology, University of Cambridge
We are delighted to announce that Grant Stewart, Chair of Kidney Cancer UK’s ‘Kidney Cancer Accord‘ steering group, is to take up... Read More
Hopes of ‘one-size-fits-all’ cancer therapy discovered
London: Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a “one-size-fits-all” cancer therapy. These... Read More
Tivozanib Shows Superior Safety Profile Across TKIs in mRCC
For the study, researchers conducted a literature review and network meta-analysis of phase 2/3 randomized controlled trials of approved first-line TKI therapies... Read More
Kidney Cancer Accord: Consensus Statement
A pathway forward
Non-invasive test that can detect kidney cancer
Renal cell carcinoma (RCC) has poor survival prognosis because it is asymptomatic at an early, more curative stage. Recently, urine perilipin-2 (PLIN-2)... Read More
Folic acid reduces mucositis in mRCC
With the introduction of tyrosine kinase inhibitors (TKI) and mTOR-inhibitors a decade ago, many metastatic RCC patients have received their treatment as... Read More
EC approves Bavencio combination
Merck and Pfizer have announced that the European Commission (EC) has approved Bavencio in combination with axitinib for the first-line treatment of... Read More
Recurrence of RCC after Robotic surgery
WCE 2019: Local Regional Recurrence of RCC after Robotic Partial Nephrectom Abu Dhabi, United Arab Emirates (UroToday.com) Mr. Ethan Wajswol began by introducing... Read More
Microwave Ablation Feasible for cT1b RCC
Microwave ablation is a feasible alternative to nephrectomy in selected patients with renal cell carcinoma (RCC) tumors that are 4 to 7... Read More
Kidney Cancer Clinical Trials: What You Need to Know
Patients with kidney cancer should be thinking about clinical trials at every step of their journey, not just after a line of... Read More
Nutrition in kidney cancer patients
While diet and exercise are a growing concern being addressed in all malignancies, its focus in kidney cancer is still lacking, according... Read More
Cell therapy trials continues after positive kidney cancer readout
Sweden’s Immunicum has announced detailed results from its mid-stage trial of its oncology cell-based immunotherapy ilixadencel, which it says justify further clinical trials... Read More
EU follows US & approves Keytruda for 1st line RCC
Merck & Co/MSD’s PD-1 inhibitor Keytruda received FDA approval earlier in 2019 for use alongside Pfizer’s Inlyta (axitinib) in previously untreated patients... Read More
Ilixadencel/Sunitinib Combo Therapy; Positive Results in mRCC
A combination therapy of ilixadencel plus sunitinib (Sutent) achieved complete tumor responses in patients with metastatic renal cell carcinoma (RCC), according to... Read More
keytruda + axitinib cleared as first-line kidney cancer treatment in EU
Merck & Co/MSD’s Keytruda has added first-line kidney cancer treatment to its ever-lengthening list of approved uses in the EU. The latest... Read More
A guide for talking about advanced cancer
Advice for people living with advanced cancer, their friends and family. We are pleased to present this informative document for the benefit... Read More
Glasgow student develops model kidney that could help train cancer surgeons
The 3D model ‘looks and feels’ like a real kidney. A student has used 3D printing technology to create a model of... Read More
Innovative Research for Advanced Kidney Cancer – David Braun
Alicia Morgans and David Braun discuss his innovative research in metastatic kidney cancer which focuses on understanding and improving immunotherapies in kidney... Read More
Setbacks and Advances in RCC Treatment
Given the variability in disease aggressiveness and the lack of highly predictive biomarkers in renal cell carcinoma (RCC), nothing resembling a “one... Read More